Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of Asia-Pacific Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 42
6 Asia-Pacific Clinical Trial Supplies Market, By Services 44
6.1 Overview 45
6.2 Storage 47
6.3 Manufacturing 49
6.4 Packaging And Labeling 50
6.5 Distribution 52
7 Asia-Pacific Clinical Trial Supplies Market, By Clinical Phases 53
7.1 Overview 54
7.2 Phase Iii 56
7.3 Phase Ii 57
7.4 Phase Iv 58
7.5 Phase I 59
8 Mjkasia-Pacific Clinical Trial Supplies Market, By Therapeutic Use 61
8.1 Overview 62
8.2 Oncology 64
8.3 Cardiovascular Disease 66
8.4 Dermatology 67
8.5 Metabolic Disorders 68
8.6 Infectious Disease 69
8.7 Respiratory Diseases 70
8.8 Cns And Mental Disorders 71
8.9 Blood Disorders 72
8.10 Others 73
9 Asia-Pacific Clinical Trial Supplies Market, By End User 74
9.1 Overview 75
9.2 Contract Research Organizations 77
9.3 Pharmaceutical And Biotechnology Companies 78
10 Asia-Pacific Clinical Trial Supplies Market, By Geography 80
10.1 Asia-Pacific 80
10.1.1 China 88
10.1.2 Japan 90
10.1.3 India 92
10.1.4 South Korea 94
10.1.5 Australia 96
10.1.6 Thailand 98
10.1.7 Malaysia 100
10.1.8 Singapore 102
10.1.9 Indonesia 104
10.1.10 Philippines 106
10.1.11 Rest Of Asia-Pacific 108
11 Asia-Pacific Clinical Trial Supplies Market, Company Landscape 109
11.1 Company Share Analysis; Asia-Pacific 109
12 Company Profile 110
12.1 Thermo Fisher Scientific Inc. 110
12.1.1 Company Overview 110
12.1.2 Revenue Analysis 110
12.1.3 Company Share Analysis 111
12.1.4 Product Portfolio 111
12.1.5 Recent Developments 112
12.2 Catalent, Inc.113
12.2.1 Company Overview 113
12.2.2 Revenue Analysis 113
12.2.3 Company Share Analysis 114
12.2.4 Product Portfolio 114
12.2.5 Recent Developments 115
12.3 Clinigen Group Plc. 116
12.3.1 Company Overview 116
12.3.2 Revenue Analysis 116
12.3.3 Revenue Analysis 117
12.3.4 Product Portfolio 117
12.3.5 Recent Developments 117
12.4 Parexel International Corporation 118
12.4.1 Company Overview 118
12.4.2 Revenue Analysis 118
12.4.3 Company Share Analysis 119
12.4.4 Product Portfolio 119
12.4.5 Recent Developments 119
12.5 Alium Medical Limited 120
12.5.1 Company Overview 120
12.5.2 Product Portfolio 120
12.5.3 Recent Developments 120
12.6 Almac Group 121
12.6.1 Company Overview 121
12.6.2 Geographic Presence 121
12.6.3 Product Portfolio 122
12.6.4 Recent Developments 122
12.7 Ancillare, Lp 123
12.7.1 Company Overview 123
12.7.2 Geographic Presence 123
12.7.3 Product Portfolio 124
12.7.4 Recent Developments 124
12.8 Biocair 125
12.8.1 Company Overview 125
12.8.2 Product Portfolio 125
12.8.3 Recent Developments 125
12.9 Bionical Ltd. 126
12.9.1 Company Overview 126
12.9.2 Gepographic Presence 126
12.9.3 Product Portfolio 127
12.9.4 Recent Developments 127
12.10 Clinical Supplies Management Holdings, Inc. 128
12.10.1 Company Overview 128
12.10.2 Geographic Presence 128
12.10.3 Product Portfolio 129
12.10.4 Recent Developments 129
12.11 Klifo 130
12.11.1 Company Overview 130
12.11.2 Geographic Presence 130
12.11.3 Product Portfolio 131
12.11.4 Recent Developments 131
12.12 Movianto 132
12.12.1 Company Overview 132
12.12.2 Geographic Presence 132
12.12.3 Product Portfolio 133
12.12.4 Recent Developments 133
12.13 Myoderm 134
12.13.1 Company Overview 134
12.13.2 Geographic Presence 134
12.13.3 Product Portfolio 135
12.13.4 Recent Developments 135
12.14 Pci Pharma Services 136
12.14.1 Company Overview 136
12.14.2 Geographic Presence 136
12.14.3 Product Portfolio 137
12.14.4 Recent Developments 137
12.15 Sharp 138
12.15.1 Company Overview 138
12.15.2 Geographic Presence 138
12.15.3 Product Portfolio 139
12.15.4 Recent Developments 140
12.16 Siro Clinpharm 141
12.16.1 Company Overview 141
12.16.2 Geographic Presence 141
12.16.3 Product Portfolio 142
12.16.4 Recent Developments 142
13 Related Reports 143
?